ICOS is essential for effective T-helper-cell responses

Anna Tafuri(Amgen (Canada)), Arda Shahinian(Ontario Institute for Cancer Research), Friedhelm Bladt(Mount Sinai Hospital), Steve K. Yoshinaga(Amgen (United States)), Manel Jordana(McMaster University), Andrew Wakeham(Ontario Institute for Cancer Research), Louis-Martin Boucher(Ontario Institute for Cancer Research), Denis Bouchard(Ontario Institute for Cancer Research), Vera Chan(Ontario Institute for Cancer Research), Gordon S. Duncan(Ontario Institute for Cancer Research), Bernhard Odermatt(University Hospital of Zurich), Alexandra Ho(Ontario Institute for Cancer Research), Annick Itié(Ontario Institute for Cancer Research), Tom Horan(Amgen (United States)), John Whoriskey(Amgen (United States)), Tony Pawson(Mount Sinai Hospital), Josef Penninger(Ontario Institute for Cancer Research), Pamela S. Ohashi(Ontario Institute for Cancer Research), Tak W. Mak(Ontario Institute for Cancer Research)

Nature

January 1, 2001

Cited by 667

Abstract

No related papers found

Powered by citation graph analysis